32 million shares short last report. Sure wuldn't want to be holding those puppies when the positive news leaks, or a partnership is announced. Al was exceptionally upbeat last CC btw, one has to wonder about that.
Good point bullcall, in fact I don't think that they have ever missed a primary endpoint. Of course this time they are aiming for superiority in one trial (I think it is just one of the two). If they nail that, and we know if user is careful they should hit it, then the FDA will have a very very rough time forcing further delays.